Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock () or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Credit NIAID-RML
Highlighted Sections
Clinical Management of Adults Summary
This section contains tables with the Panel’s recommendations for the therapeutic management of adults with COVID-19.
Immunocompromised
The Panel discusses preventing SARS-CoV-2 infection
and treating COVID-19 in patients who are immunocompromised.
Paxlovid Drug-Drug Interactions
This section provides resources for identifying and managing interactions between ritonavir-boosted nirmatrelvir and concomitant medications.
Clinical Management of Children Summary
The tables in this section summarize the Panel’s recommendations for the therapeutic management of children with COVID-19 or MIS-C.
Hospitalized Adults: Therapeutic Management
For patients who require high-flow nasal cannula oxygen or noninvasive ventilation, the Panel recommends using a combination of 2 immunomodulators.
Nonhospitalized Children: Therapeutic Management
In this new section, the Panel provides treatment recommendations for nonhospitalized children that are stratified by age and risk of disease progression.
Clinical Management of Adults Summary
This section contains tables with the Panel’s recommendations for the therapeutic management of adults with COVID-19.
Immunocompromised
The Panel discusses preventing SARS-CoV-2 infection
and treating COVID-19 in patients who are immunocompromised.
Paxlovid Drug-Drug Interactions
This section provides resources for identifying and managing interactions between ritonavir-boosted nirmatrelvir and concomitant medications.
Clinical Management of Children Summary
The tables in this section summarize the Panel’s recommendations for the therapeutic management of children with COVID-19 or MIS-C.
Hospitalized Adults: Therapeutic Management
For patients who require high-flow nasal cannula oxygen or noninvasive ventilation, the Panel recommends using a combination of 2 immunomodulators.
Nonhospitalized Children: Therapeutic Management
In this new section, the Panel provides treatment recommendations for nonhospitalized children that are stratified by age and risk of disease progression.
Clinical Management of Adults Summary
This section contains tables with the Panel’s recommendations for the therapeutic management of adults with COVID-19.
Immunocompromised
The Panel discusses preventing SARS-CoV-2 infection
and treating COVID-19 in patients who are immunocompromised.
Paxlovid Drug-Drug Interactions
This section provides resources for identifying and managing interactions between ritonavir-boosted nirmatrelvir and concomitant medications.
Clinical Management of Children Summary
The tables in this section summarize the Panel’s recommendations for the therapeutic management of children with COVID-19 or MIS-C.
Hospitalized Adults: Therapeutic Management
For patients who require high-flow nasal cannula oxygen or noninvasive ventilation, the Panel recommends using a combination of 2 immunomodulators.
Nonhospitalized Children: Therapeutic Management
In this new section, the Panel provides treatment recommendations for nonhospitalized children that are stratified by age and risk of disease progression.